Fresenius Medical Care Corporation Stock price history, chart, earnings

Fresenius medical care corporation

Health-Care > Hospital/Nursing-Management

FMS

News

Fresenius Medical Care increased 0.4% to €27.71 after the dialysis service provider lifted its annual outlook.

Revenue in the third quarter declined 3% to €4.9 billion from €5.03 billion, net income fell to €84 million from €230 million, and net income dropped to 29 cents from 7 cents a year ago.

The company reiterated its 2023 revenue to grow at a low to mid-single-digit percentage rate from €19.4 billion in 2022.

The company raised its 2023 operating earnings to grow at a low single-digit percentage rate from €1.54 billion in 2022, from the previous outlook of flat to a decline in the low single-digit percentage rate.

The German company also said it had resolved its legal dispute with the U.S. Department of Defense and finalized its settlement for payment of dialysis services provided under the Tricare program to members of military service, their dependents, and retirees.

The company sought to receive payment for services provided under the Tricare program on or before January 11, 2023.

As a consequence of the settlement agreement, Fresenius anticipates a positive impact on operating income of €175 million in the fourth quarter.
Nov 22, 2023

Fresenius Medical SE increased 6.9% to €27.21 after the German dialysis company reported adjusted earnings that were ahead of expectations.

Revenue in the first quarter increased 3.4% to €4.7 billion and net income fell 45.1% to €86 million from €157 million and basic earnings per share declined to 29 cents from 54 cents a year ago.

Adjusted earnings per share, which excludes the U.S. Provider Relief Funding and Ukraine war related items among other adjustments, declined to 53 cents from 67 cents a year ago.

Fresenius forecasted 2023 annual revenue "to grow at a low to mid-single digit percentage rate" from €19.39 billion and operating income to remain "flat or decline by up to a high-single digit percentage rate" from €1.54 billion.
May 9, 2023

Links

Website

Investor Relation

10K

10Q

Prospectus

Price

Last Close
$ 21.61 0.65 % +0.14
May 15, 2026

Trading Volume
23,918

52-Week High/Low
$24 - $16

Market Cap Full
$ 5.7B

2025	2026
$ 0	-

Trailing	Forward
0	-

Date	Shares	Ratio
Sep 30, 2019	313100	0.11

Returns +
Q

	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Q1	-1.4%	-1.1%	-7.4%	30.1%	3.8%	-11.3%	-5%	25.1%	-2.8%	-0.2%	-
Q2	-	-4.7%	0.5%	12.5%	-26%	12.7%	4%	-3.6%	1.2%	16%	-
Q3	-	-4.7%	0.4%	-10%	-43.7%	-15.9%	8%	-15.8%	2.8%	1.2%	-
Q4	-	-4.7%	-5.7%	-2.2%	16.4%	-7.2%	-2.2%	9.5%	-38.7%	6.3%	-

Returns +
M

	J	F	M	A	M	J	J	A	S	O	N	D
2026	-	-	-	-	-	-	-	-	-	-	-	-
2025	-1.1%	-	-	-	-	-	-	-	-	-	-	-

Returns +
A

	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
FMS	-3%	-1%	9%	28%	-50%	-22%	13%	13%	-38%	26%	2%

Earnings

	id	company_name	ticker	sector	industry	addresss	state	city	zip	country
Q1
Q2
Q3
Q4
A

Financial
Statements

Income Statement

Millions of USD $ except per share data	2020-12-31	2019-12-31	2018-12-31
Revenue	20400.41	19573.74	19541.86
Cost Of Goods Sold	14074.98	13530.39	13454.11
			More

Millions of USD $ except per share data	2020-12-31	2019-12-31	2018-12-31
Cash On Hand	1235.442	1128.65	2533.991
Notes And Loans Receivable	-	-	-
			More

Millions of USD $ except per share data	2020-12-31	2019-12-31	2018-12-31
Net Income/Loss	1640.151	1611.12	2628.501
Total Depreciation And Amortization - Cash Flow	2040.032	1784.339	856.044
			More

Income Statement

Millions of USD $ except per share data	2022-12-31	2022-09-30	2022-06-30
Revenue	5138.652	5132.858	5062.059
Cost Of Goods Sold	3756.441	3764.49	3629.592
			More

Millions of USD $ except per share data	2021-09-30	2021-06-30	2021-03-31
Cash On Hand	1841.715	1696.449	1294.185
Notes And Loans Receivable	-	-	-
			More

Annual
Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Dividend +

	2024	2023	2022	2021
Q1	0.44	0.42	0.49	0.57
Q2	-	-	-	-
Q3	-	-	-	-
Q4	-	-	-	-
A	0.44	0.42	0.49	0.57

Data Sources Disclaimer

Fresenius Medical Care Corporation

Fresenius medical care corporation

News

Links

Price

Earnings

Gain

Returns +
Q

Returns +
M

Returns +
A

Earnings

Financial
Statements

Income Statement

Balance Sheet

Cash Flow Statement

Income Statement

Balance Sheet

Annual
Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Dividend +

FMS	3.25%
S&P 500	%

Fresenius Medical Care Corporation

Fresenius medical care corporation

News

Links

Price

Earnings

Gain

Returns +Q

Returns + M

Returns + A

Earnings

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Income Statement

Balance Sheet

Annual Returns

52 Week High/Low

Annual Earnings

Chart

Trading Volume

Dividend +

Returns +
Q

Returns +
M

Returns +
A

Financial
Statements

Annual
Returns

52 Week
High/Low

Annual
Earnings